- Carragelose eye drops for the treatment of dry eyes launched under the trade name “Coldamaris protect” in Austria
- Eye drops complement existing Carragelose product portfolio now owned by Unither Pharmaceuticals and are important for reaching contractually agreed earn-out milestones
- Furthermore, the decongestant Carragelose-containing nasal spray has received declaration of conformity under the new medical device regulation (MDR)
The full press release is available as download here: